Clinical Trial Update: Low Dose ICG for Biliary Tract and Tumor Imaging [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose indocyanine green (ICG) for biliary tract and tumor imaging completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholecystitis
• Hepatocellular Carcinoma
• Liver Metastases

Drugs mentioned

• Indocyanine Green (ICG) (indocyanine green)

Snippet

Sponsor: University of Florida | Conditions: Cholecystitis, Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-08-30